Ramy Farid insider trades

Open-market stock purchases and sales by Ramy Farid, Director at Vir Biotechnology, Inc, from SEC Form 4 filings since Feb 10, 2020.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +140%.

Recent trades

DateStockTradeValue
May 27, 2026VIR Vir Biotechnology, IncBought (not open market)—
May 27, 2026VIR Vir Biotechnology, IncBought (not open market)—
Apr 17, 2026SDGR Schrodinger, IncSold$525K
Apr 17, 2026SDGR Schrodinger, IncBought (not open market)—
Apr 17, 2026SDGR Schrodinger, IncBought (not open market)—
Apr 16, 2026SDGR Schrodinger, IncBought (not open market)—
Apr 16, 2026SDGR Schrodinger, IncSold$530K
Mar 5, 2026SDGR Schrodinger, IncSold$47.2K
Mar 2, 2026SDGR Schrodinger, IncBought (not open market)—
Mar 2, 2026SDGR Schrodinger, IncBought (not open market)—
Mar 2, 2026SDGR Schrodinger, IncSold$66.2K
Mar 2, 2026SDGR Schrodinger, IncBought (not open market)—
Mar 2, 2026SDGR Schrodinger, IncBought (not open market)—

Companies traded

  • VIR Vir Biotechnology, Inc: other filings, last May 27, 2026
  • SDGR Schrodinger, Inc: 15 sales, last Apr 17, 2026
  • GPCR Structure Therapeutics Inc: 1 buy, last Feb 7, 2023

Get free alerts when Ramy Farid files a new trade →